{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:01:16Z","timestamp":1787497276660,"version":"build-2736575974"},"reference-count":54,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["110043"],"award-info":[{"award-number":["110043"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR57\/P06"],"award-info":[{"award-number":["SFB-TRR57\/P06"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LU 1360\/3-1"],"award-info":[{"award-number":["LU 1360\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG RO 4317\/4-1"],"award-info":[{"award-number":["DFG RO 4317\/4-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009398","name":"Medizinische Fakult\u00e4t, RWTH Aachen University","doi-asserted-by":"publisher","award":["None"],"award-info":[{"award-number":["None"]}],"id":[{"id":"10.13039\/501100009398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210944","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T14:00:55Z","timestamp":1547733655000},"page":"e0210944","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":53,"title":["Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma"],"prefix":"10.1371","volume":"14","author":[{"given":"Sven H.","family":"Loosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Wiltberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael","family":"Vucur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob N.","family":"Kather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Paffenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian T.","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-6362","authenticated-orcid":true,"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"N Razumilava","year":"2014","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"A Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","article-title":"Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States","volume":"33","author":"T. Patel","year":"2001","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/annonc\/mdw324","article-title":"Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"27","author":"JW Valle","year":"2016","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.12659\/MSM.895040","article-title":"Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis","volume":"21","author":"B Liang","year":"2015","journal-title":"Med Sci Monit"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"CA 19\u20139 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"19","author":"E Bj\u00f6rnsson","year":"1999","journal-title":"Liver"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.21873\/anticanres.11142","article-title":"MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy","volume":"36","author":"B D\u2019Angelo","year":"2016","journal-title":"Anticancer Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138920210793175895","article-title":"MicroRNA: Biogenesis, Function and Role in Cancer","volume":"11","author":"L-A Macfarlane","year":"2010","journal-title":"Curr Genomics"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/cdd.2009.105","article-title":"MicroRNAs as regulators of death receptors signaling","volume":"17","author":"M Garofalo","year":"2010","journal-title":"Cell Death Differ"},{"key":"ref10","article-title":"Interplay of mitochondrial metabolism and microRNAs","author":"J Geiger","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.stem.2010.06.012","article-title":"MicroRNAs as regulators of differentiation and cell fate decisions","volume":"7","author":"KN Ivey","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010078","article-title":"Circulating MicroRNAs as Biomarkers for Sepsis","volume":"17","author":"F Benz","year":"2016","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury","volume":"106","author":"K Wang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"PS Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"X Chen","year":"2008","journal-title":"Cell Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e28486","DOI":"10.1371\/journal.pone.0028486","article-title":"Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection","volume":"6","author":"P Qi","year":"2011","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mc.20712","article-title":"Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis","volume":"50","author":"J Xu","year":"2011","journal-title":"Mol Carcinog"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1373\/clinchem.2011.172767","article-title":"Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer","volume":"58","author":"R Liu","year":"2012","journal-title":"Clin Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1158\/1940-6207.CAPR-09-0094","article-title":"MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease","volume":"2","author":"J Wang","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e0163699","DOI":"10.1371\/journal.pone.0163699","article-title":"Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma","volume":"11","author":"C Correa-Gallego","journal-title":"PLoS One"},{"key":"ref21","first-page":"748","article-title":"[Regulatory role of serum miR-224 in invasiveness and metastasis of cholangiocarcinoma]","volume":"23","author":"M Huang","year":"2015","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13054-015-0988-4","article-title":"Persistently elevated osteopontin serum levels predict mortality in critically ill patients","volume":"19","author":"C Roderburg","year":"2015","journal-title":"Crit Care"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"A Koch","year":"2011","journal-title":"Crit Care"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3748\/wjg.v10.i3.427","article-title":"Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA","volume":"10","author":"X-L Qin","year":"2004","journal-title":"World J Gastroenterol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"16975","DOI":"10.1038\/s41598-017-17175-7","article-title":"CEA but not CA19-9 is an independent prognostic factor in patients undergoing resection of cholangiocarcinoma","volume":"7","author":"SH Loosen","year":"2017","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40139-014-0048-9","article-title":"MicroRNAs in Cholangiopathies","volume":"2","author":"SP O\u2019Hara","year":"2014","journal-title":"Curr Pathobiol Rep"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0034-1397346","article-title":"MicroRNAs and benign biliary tract diseases","volume":"35","author":"SA Gradilone","year":"2015","journal-title":"Semin Liver Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e23937","DOI":"10.1371\/journal.pone.0023937","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease","volume":"6","author":"S Cermelli","year":"2011","journal-title":"PLoS One"},{"key":"ref30","article-title":"MicroRNAs and liver disease","author":"M Otsuka","year":"2016","journal-title":"J Hum Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"LA Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"YH Shaib","year":"2004","journal-title":"J Hepatol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"N Razumilava","year":"2014","journal-title":"Lancet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s12094-015-1294-y","article-title":"Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis","volume":"17","author":"G Li","year":"2015","journal-title":"Clin Transl Oncol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/cas.12300","article-title":"Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer","volume":"104","author":"T Kishimoto","year":"2013","journal-title":"Cancer Sci"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3892\/or.2014.3641","article-title":"Upregulated circulating miR-150 is associated with the risk of intrahepatic cholangiocarcinoma","volume":"33","author":"S Wang","year":"2015","journal-title":"Oncol Rep"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.12776","article-title":"Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"185","author":"F Bernuzzi","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"ref38","first-page":"2016","article-title":"Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma","author":"X Wu","year":"2016","journal-title":"Tumour Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s40291-015-0148-1","article-title":"Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection","volume":"19","author":"NE EL-Abd","year":"2015","journal-title":"Mol Diagn Ther"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1093\/carcin\/bgp283","article-title":"An insertion\/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3\u2019 untranslated region confers risk for hepatocellular carcinoma","volume":"30","author":"Y Gao","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e1005726","DOI":"10.1371\/journal.pgen.1005726","article-title":"MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma","volume":"11","author":"Y Ge","year":"2015","journal-title":"PLoS Genet"},{"key":"ref42","first-page":"351","article-title":"[miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?]","volume":"61","author":"P \u0160krha","year":"2015","journal-title":"Vnitr Lek"},{"key":"ref43","first-page":"539","article-title":"The role of miR-29b in cancer: regulation, function, and signaling","volume":"8","author":"B Yan","year":"2015","journal-title":"Onco Targets Ther"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.27200","article-title":"Modulation of miR-29 expression by \u03b1-fetoprotein is linked to the hepatocellular carcinoma epigenome","volume":"60","author":"S Parpart","year":"2014","journal-title":"Hepatology"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejcb.2012.11.004","article-title":"The role of miRNA-29 family in cancer","volume":"92","author":"Y Wang","year":"2013","journal-title":"Eur J Cell Biol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1007\/s13277-014-2479-7","article-title":"Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1","volume":"35","author":"G Lao","year":"2014","journal-title":"Tumour Biol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bios.2016.02.035","article-title":"Novel and simple electrochemical biosensor monitoring attomolar levels of miRNA-155 in breast cancer","volume":"80","author":"AR Cardoso","year":"2016","journal-title":"Biosens Bioelectron"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e99431","DOI":"10.1371\/journal.pone.0099431","article-title":"The real-time dynamic monitoring of microRNA function in cholangiocarcinoma","volume":"9","author":"X Chen","year":"2014","journal-title":"PLoS One"},{"key":"ref49","article-title":"Cell-specific functions of miRNA in the liver","author":"C Roderburg","year":"2016","journal-title":"J Hepatol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPG.0b013e318244148b","article-title":"MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia","volume":"54","author":"NJ Hand","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"C Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1038\/sj.onc.1210436","article-title":"mir-29 regulates Mcl-1 protein expression and apoptosis","volume":"26","author":"JL Mott","year":"2007","journal-title":"Oncogene"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/liv.12627","article-title":"Elevated miR-122 serum levels are an independent marker of liver injury in inflammatory diseases","volume":"35","author":"C Roderburg","year":"2015","journal-title":"Liver Int"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"7912","DOI":"10.4238\/2014.September.29.4","article-title":"Expression and clinical significance of miR-122 and miR-29 in hepatitis B virus-related liver disease","volume":"13","author":"TJ Xing","year":"2014","journal-title":"Genet Mol Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:09:55Z","timestamp":1589004595000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210944"}},"subtitle":[],"editor":[{"given":"Niklas K.","family":"Bj\u00f6rkstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210944","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]}}}